JP2025505187A - 体重減少の方法および骨格筋量を保存する方法 - Google Patents

体重減少の方法および骨格筋量を保存する方法 Download PDF

Info

Publication number
JP2025505187A
JP2025505187A JP2024546277A JP2024546277A JP2025505187A JP 2025505187 A JP2025505187 A JP 2025505187A JP 2024546277 A JP2024546277 A JP 2024546277A JP 2024546277 A JP2024546277 A JP 2024546277A JP 2025505187 A JP2025505187 A JP 2025505187A
Authority
JP
Japan
Prior art keywords
subject
fat
reduction
per day
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024546277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505187A5 (https=
JPWO2023150767A5 (https=
Inventor
シャハリヤール カーン，
ダイアン ジョカスキー，
フランシスコ ポルテル，
Original Assignee
リーバス ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リーバス ファーマシューティカルズ， インコーポレイテッド filed Critical リーバス ファーマシューティカルズ， インコーポレイテッド
Publication of JP2025505187A publication Critical patent/JP2025505187A/ja
Publication of JP2025505187A5 publication Critical patent/JP2025505187A5/ja
Publication of JPWO2023150767A5 publication Critical patent/JPWO2023150767A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024546277A 2022-02-07 2023-02-06 体重減少の方法および骨格筋量を保存する方法 Pending JP2025505187A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263307506P 2022-02-07 2022-02-07
US63/307,506 2022-02-07
US202263382456P 2022-11-04 2022-11-04
US63/382,456 2022-11-04
PCT/US2023/062077 WO2023150767A1 (en) 2022-02-07 2023-02-06 Methods of weight loss and preserving skeletal muscle mass

Publications (3)

Publication Number Publication Date
JP2025505187A true JP2025505187A (ja) 2025-02-21
JP2025505187A5 JP2025505187A5 (https=) 2026-02-16
JPWO2023150767A5 JPWO2023150767A5 (https=) 2026-02-16

Family

ID=85556813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546277A Pending JP2025505187A (ja) 2022-02-07 2023-02-06 体重減少の方法および骨格筋量を保存する方法

Country Status (12)

Country Link
US (1) US20250134864A1 (https=)
EP (1) EP4475841A1 (https=)
JP (1) JP2025505187A (https=)
KR (1) KR20240146052A (https=)
AU (1) AU2023216366A1 (https=)
CA (1) CA3243640A1 (https=)
CL (1) CL2024002341A1 (https=)
GE (1) GEAP202416578A (https=)
IL (1) IL314684A (https=)
JO (1) JOP20240177A1 (https=)
MX (1) MX2024009646A (https=)
WO (1) WO2023150767A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025199516A1 (en) * 2024-03-22 2025-09-25 Board Of Regents, The University Of Texas System Compositions and methods for preserving or increasing lean muscle mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3565806T (pt) 2017-01-06 2022-05-19 Rivus Pharmaceuticals Inc Novos derivados de fenilo

Also Published As

Publication number Publication date
US20250134864A1 (en) 2025-05-01
CA3243640A1 (en) 2023-08-10
JOP20240177A1 (ar) 2024-08-04
GEAP202416578A (en) 2024-11-11
WO2023150767A1 (en) 2023-08-10
EP4475841A1 (en) 2024-12-18
IL314684A (en) 2024-10-01
CL2024002341A1 (es) 2025-01-17
KR20240146052A (ko) 2024-10-07
MX2024009646A (es) 2024-11-08
AU2023216366A1 (en) 2024-08-15

Similar Documents

Publication Publication Date Title
TW202323296A (zh) 組合療法
JP2017513836A (ja) Ｎａｆｌｄおよびｎａｓｈの治療
CN107683135A (zh) 用于治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法
CN113301889A (zh) Nafld和nash的联合治疗
WO2020102351A1 (en) Treatment of obesity and its complications
JP2024529452A (ja) 長時間作用型ｇｌｐ１／グルカゴン受容体アゴニストのための投薬レジメン
TW202114671A (zh) 包含fxr促效劑之治療
CN109195594A (zh) 肝内胆汁淤积性疾病的治疗
JP2025505187A (ja) 体重減少の方法および骨格筋量を保存する方法
TW202313010A (zh) 治療粒線體相關病症之方法
TW202114654A (zh) 包含如sglt 1/2抑制劑的sglt抑制劑之治療
JP2025505632A (ja) 上昇したＨｂＡ１ｃを有する対象における体重減少の方法
CN118900692A (zh) HbA1c升高的受试者的体重减轻方法
CN118922187A (zh) 体重减轻和保持骨骼肌量的方法
CN112107581A (zh) 式i化合物在制备治疗肥胖及相关病症的药中的用途
WO2026046202A1 (zh) Glp-1/gip肽或含有其的药物组合物的用途
TW202500575A (zh) 具有或不具有體重相關合併症之過重或肥胖成人之治療
CN117881399A (zh) 治疗粒线体相关病症的方法
CN121969358A (zh) 选择性雄激素受体调节剂（sarm）化合物在长期体重管理中的用途
WO2026037397A1 (zh) Glp-1类似物的医药用途
TW202033199A (zh) 化合物ａ與化合物ｂ聯合在製備治療痛風或高尿酸血症的藥物中的用途
WO2026021478A1 (zh) Ar降解剂与parp1抑制剂联合用于治疗前列腺癌的方法
JP2018108969A (ja) リンパ浮腫の治療薬
EA042686B1 (ru) Способ лечения неалкогольного стеатогепатита
BR112019010236B1 (pt) Formulações tamponadas de exendina (9-39) e uso das mesmas

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260205

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260205